3-HO-PCP Powder 

€ 25,00

3-HO-PCP Powder is described as a laboratory research material associated with 3-hydroxyphencyclidine, a synthetic hydroxy-substituted arylcyclohexylamine structurally related to phencyclidine (PCP).

Raw Lab Chems identifies this material exclusively for controlled chemical identification, chromatographic characterization, spectroscopic investigation, and analytical reference comparisons involving arylcyclohexylamine derivatives.

The supplied information includes claims concerning purity, independent testing, batch traceability, and specialized packaging. These specifications require supporting batch-specific documentation before they can be considered verified.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-S-12437 Category:
Description

3-HO-PCP Powder – 3-Hydroxyphencyclidine Research Material

Product Overview

3-HO-PCP Powder is described in the supplied information as a laboratory research material associated with 3-hydroxyphencyclidine, a synthetic compound belonging to the arylcyclohexylamine family.

The compound is structurally related to phencyclidine, commonly abbreviated PCP, and is distinguished by a hydroxy substituent on the aromatic ring.

Its chemical classification provides a basis for analytical investigations involving structural comparison, chromatographic behavior, and spectroscopic characterization.

Raw Lab Chems presents the material exclusively within a Research Use Only framework.

The supplied source describes a fine crystalline powder intended for controlled laboratory examination.

However, the stated physical presentation does not independently establish the actual chemical identity, purity, crystalline structure, or composition of the material.

The source also characterizes the preparation as laboratory-grade and refers to independent analytical verification and controlled manufacturing conditions.

These descriptions remain supplier-provided claims until supported by documentation associated with the actual batch.

No clinical, therapeutic, diagnostic, dietary, or consumer-oriented application is represented by this description.

Chemical Identity & Classification

3-HO-PCP is the abbreviated name for 3-hydroxyphencyclidine.

The supplied source also uses the alternative designation 3-hydroxy PCP.

The compound is described as a hydroxy-substituted derivative of phencyclidine within the arylcyclohexylamine family.

Its proposed structure differs from the parent compound through the presence of a hydroxy group on the aromatic ring.

The supplied source provides the following chemical-reference information:

  • Chemical name: 3-Hydroxyphencyclidine
  • Common abbreviation: 3-HO-PCP
  • Alternative name: 3-Hydroxy PCP
  • Chemical classification: Hydroxy-substituted arylcyclohexylamine derivative
  • Reported molecular formula: C17H25NO
  • Reported molecular weight: 259.39 g/mol

These identifiers are reproduced from the supplied information and do not independently verify the composition of the actual product.

The reported molecular formula and molecular weight are arithmetically consistent with one another.

However, this consistency does not establish that the actual material has been independently identified or that its precise chemical form is confirmed.

No CAS Registry Number was supplied.

The source also does not establish whether the preparation is the freebase or a particular salt form.

This distinction matters because chemical form can affect molecular weight, solubility, and other analytical characteristics.

Researchers seeking public chemical-reference information may consult PubChem and confirm that any selected database entry corresponds to the intended compound and chemical form.

Chemical & Physical Characteristics

The supplied product is described as a fine crystalline powder.

No product-specific physical inspection record, microscopy report, diffraction dataset, or other evidence was provided to establish its actual appearance or crystalline state.

The stated physical form therefore remains a source-provided description.

The hydroxy-substituted arylcyclohexylamine structure provides a framework for comparing chemical characteristics with those of related PCP derivatives.

However, structural similarity does not establish identical physical properties, analytical behavior, stability, or impurity profiles.

The source references chromatographic separation and spectroscopic characterization as areas of laboratory investigation.

No verified melting point, quantitative solubility profile, particle-size distribution, crystalline polymorph, density, or hygroscopicity measurement was supplied.

These characteristics should not be inferred from the compound name or chemical family.

The source recommends storage in a cool, dry place protected from light and suggests refrigeration at 2–8°C for longer-term stability.

No validated stability study, degradation profile, or experimentally established shelf-life specification accompanied this recommendation.

Researchers should distinguish general storage guidance from verified stability data associated with a particular batch.

Purity & Analytical Verification

The supplied description claims purity of at least 98%, characterized as typical and independently verified.

However, no actual batch-specific Certificate of Analysis, chromatogram, mass spectrum, NMR spectrum, or independent laboratory report was provided.

Accordingly, the stated purity threshold is not independently confirmed for the material described here.

The source identifies HPLC, GC-MS, LC-MS, and NMR spectroscopy as analytical techniques associated with arylcyclohexylamine investigation.

Such methods may provide information concerning chemical identity, structural characteristics, impurity profiles, and analytical specificity.

However, naming an analytical technique does not establish that it was performed on the actual product.

The source also references forensic chemical identification and analytical detection in complex matrices as research topics.

These references describe possible analytical investigation areas rather than validated performance characteristics of the supplied material.

Any reported purity or identity result should be evaluated against the actual sample, method documentation, reference materials, and relevant analytical limitations.

No certified reference-material status or independently established purity specification is asserted.

Quality Control & Batch Integrity

The supplied source claims that individual batches undergo third-party testing and are supported by Certificates of Analysis available upon request.

It also describes batch traceability, verification of identity and purity, and controlled manufacturing conditions.

No actual certificate, laboratory accreditation record, manufacturing audit, quality-system documentation, or batch-specific testing report accompanied these statements.

They therefore remain unverified supplier claims.

For reproducible laboratory investigation, useful documentation may include supplier identification, batch number, chemical identifier, receipt date, storage history, and available analytical findings.

Where a material is described as suitable for reference-standard work, researchers should distinguish ordinary catalog material from a certified reference material.

The supplied information does not establish certified reference-material status, metrological traceability, or an assigned measurement uncertainty.

Likewise, the description does not independently demonstrate compliance with a particular quality-management certification.

Claims of consistent purity, identity, or manufacturing quality should be supported by actual analytical records rather than inferred from catalog terminology.

Safety, Handling & Laboratory Precautions

3-Hydroxyphencyclidine is described as a phencyclidine-related arylcyclohexylamine derivative requiring appropriate institutional risk assessment and controlled laboratory handling.

Research personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.

Laboratory precautions should address access restrictions, protective equipment, contamination prevention, accidental exposure, environmental release, and chemical-waste disposal.

The compound’s structural relationship to PCP does not establish safety for human or veterinary exposure.

The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.

Because the actual purity and chemical form have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements.

The powder presentation must not be interpreted as evidence of pharmaceutical suitability or authorization for personal use.

Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.

Packaging, Labeling & Storage

The supplied source describes secure packaging, appropriate chemical labeling, and professional handling during transportation.

No packaging-validation study, verified container specification, or actual shipment-condition record accompanied these claims.

The source recommends cool, dry storage protected from light and suggests refrigeration at 2–8°C.

No validated stability data was provided to establish that this temperature range is necessary or sufficient for a particular shelf life.

The source also claims that shipping arrangements support regulatory compliance and safe transit.

No shipment classification, carrier documentation, or compliance record was supplied to substantiate those statements.

Laboratory inventory records should preserve the compound name, any available batch identifier, receipt details, and relevant storage observations.

Where chemical form remains uncertain, the inventory record should preserve that uncertainty rather than assign an unverified salt designation.

Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional laboratory procedures.

Intended Research Use & Market Positioning

The supplied scientific context places 3-HO-PCP within analytical research involving arylcyclohexylamine derivatives, chemical characterization, structural comparison, and forensic identification.

Its hydroxy-substituted structure provides a basis for examining distinctions among related PCP derivatives.

The source also references chromatographic separation, mass-spectrometric characterization, and spectroscopic investigation as areas of laboratory research.

These references describe analytical research contexts and do not establish any human-use application.

For comparative chemical-catalog research, Raw Lab Chems also lists 3-HO-PCE Powder and 3-Me-PCE Powder.

These listings identify other named arylcyclohexylamine research materials but do not establish equivalent chemical identity, purity, formulation, or analytical characteristics.

The supplied 3-HO-PCP Powder catalog reference identifies the product presentation discussed here.

These references provide chemical-catalog context rather than evidence of certified reference-material status or interchangeability.

Ordering, Availability & Fulfillment

The supplied source describes worldwide shipping, discreet packaging, tracking, and transportation through compliant carriers.

No current inventory information, carrier record, destination-specific authorization, or verified shipment-performance documentation was provided.

Consequently, no specific availability, delivery, customs-clearance, or transportation-compliance guarantee is asserted.

Phencyclidine-related arylcyclohexylamines may be subject to controlled-substance or analog legislation.

Institutional acquisition and transfer should therefore be assessed against the applicable laws governing the exact substance and chemical form involved.

Researchers and institutions should independently verify whether possession, importation, exportation, transportation, and laboratory investigation are authorized in their jurisdictions.

Research-only labeling does not establish an exemption from controlled-substance regulations.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

3-HO-PCP is described as a hydroxy-substituted arylcyclohexylamine derivative whose legal classification may vary by jurisdiction.

Acquisition, possession, transfer, importation, exportation, storage, and laboratory investigation may be restricted or prohibited under applicable controlled-substance, analog, or other chemical regulations.

Researchers and institutions remain responsible for determining legal requirements and obtaining any necessary authorizations.

No medical approval, consumer-use authorization, universal legal status, or regulatory exemption is implied by this description.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “3-HO-PCP Powder ”
Shipping & Delivery